Home
Ait Bioscience

Ait Bioscience Market Share Analysis for April 2026

on the forefront of covid-19 recognized leader in the covid-19 field by governmental and non-governmental organizations as the reference assay...

Industry: N/A

Domainaitbioscience.com

Year Founded2009

Employees51 - 200

Annual Revenue$10M - $15M

Ait Bioscience

Ait Bioscience (including company regionals)

aitbioscience.com

See more website traffic and engagement information

Ait Bioscience Revenue up to April 2026 is 10M - 15M

revenue generated by Ait Bioscience top domains

Ait Bioscience top domains revenue over 3 years

Revenue for Ait Bioscience top domains

aitbioscience.com10M - 15M

See more with Sales Intelligence

Total visits to Ait Bioscience's top domains

Understand Ait Bioscience market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Ait Bioscience's top domains

Analyze Ait Bioscience engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Ait Bioscience's top domains

See how Ait Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Ait Bioscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ait Bioscience

These are the website technologies, by industry, used by Ait Bioscience top domains

Advertising (8)

DoubleClick

Social (5)

Facebook Connect

Widget (5)

Twemoji

Marketing (4)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Ait Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAitbioscience hires Victor Wroblewski as VP of Biotherapeutic Development LBA.AIT Bioscience, a premier bioanalytical CRO in Indianapolis, IN, welcomes Victor Wroblewski as VP of Biotherapeutic Development LBA.

NewsNexelis acquires Aitbioscience.Nexelis, a portfolio company of Ampersand Capital Partners, has acquired AIT Bioscience, an Indianapolis-based bioanalytical contract research organization.

NewsAitbioscience partnered with Karyopharm Therapeutics Inc on May 5th '20.INDIANAPOLIS, INDIANA, USA, May 5, 2020 / EINPresswire.com / -- AIT Bioscience, a premier bioanalytical contract research organization (CRO), announced a collaboration with Karyopharm Therapeutics Inc. (Nasdaq: KPTI) to provide bioanalytical analysis of clinical trial samples to speed patient access to a potential COVID-19 treatment.